Skip to main content

Table 1 Patient and disease characteristics

From: Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

 

Experimental group N = 14

Control group N = 88

Age (median)

66.5 years (range 47–75 years)

59 years (range 26–76)

Gender

Female 42.9%

Female 51.8%

Male 57.1%

Male 48.2%

BMI (median)

26.4 (range 20.31–35.08)

23.7 (range 11.47–40.04)

Origin of peritoneal carcinomatosis

Colorectal 14

Colorectal 110

  1. BMI body mass index